Semi-Q-RT-PCR | Open Access Journals

Journal of Biomedical Systems & Emerging Technologies

ISSN: 2952-8526

Open Access


Antiviral medical aid may be avoided throughout the low replicative part of chronic serum hepatitis virus (HBV) infection that is characterised notably by HBV DNA concentration below 2000 IU/ml. Simplified diagnostic tests will improve access to HBV DNA observation in resource-limited settings. The capability of a replacement semi-quantitative period of time PCR approach supported sample-to-standard relative detection of the target to discriminate samples with HBV DNA levels on top of or below the clinical threshold of 2000 IU/ml was compared to a quantitative assay (Roche CobasAmpliPrep/CobasTaqMan HBV check v2.0). The semi-quantitative assay properly known 40/40 (100%) low replicative HBV DNA patients and 58/61 (95%) samples from HBV-infected subjects with moderate/high levels of infective agent DNA. Our results advised that this different PCR check is economical to guide therapeutic call supported identification of low replicative HBV infection from all of the chronic serum hepatitis carriers requiring treatment, and will be helpful in resource-limited settings wherever the overwhelming majority of cases live. semiquantitative RT-PCR protocol optimized in our laboratory to extract RNA from as very little as ten,000 cells and to live the expression levels of many target mRNAs from every sample. This procedure was optimized on the human erythroleukemia cell line TF-1 however was with success used on primary cells and on completely different cell lines. we tend to describe the elaborated procedure for the analysis of Bcl-2 levels. Aldolase A was used as an inside management to normalize for sample to sample variations in total RNA amounts and for reaction potency.

High Impact List of Articles

Relevant Topics in Science & Technology

Google Scholar citation report
Citations: 47

Journal of Biomedical Systems & Emerging Technologies received 47 citations as per Google Scholar report

Journal of Biomedical Systems & Emerging Technologies peer review process verified at publons

Indexed In

arrow_upward arrow_upward